George Avgerinos
CIK 1578699 · SVP, BIOLOGICS OPERATIONS · last filed 2019-07-09
George Avgerinos is a SVP, BIOLOGICS OPERATIONS who has filed 17 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for FBIOP, was dated Jul 9, 2019. Across all open-market trades the lifetime net is −$429.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.7M across reported positions. 18 SEC filings were submitted jointly with Fortress Biotech, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FBIOP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
24 NEW ENGLAND EXECUTIVE PARK
BURLINGTON, MA 01803
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBIOP | SVP, BIOLOGICS OPERATIONS | 655,170 | $16.20 | $10.61M | -$304.5K | 4 | 2019-07-09 |
| FBIO | SVP, Biologics Operations | 19,533 | $1.87 | $36.5K | -$124.6K | 12 | 2016-09-19 |
| Fortress Biotech, Inc. (CNDO) Delisted | SVP, Biologics Operations | 8,000 | — | — | $0 | 1 | 2013-06-06 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-09 | FBIOP | Grant (A) | +400,000 | $0 | EDGAR |
| 2018-12-13 | FBIOP | Sell (S) | −97,325 | -$102.2K | EDGAR |
| 2017-12-18 | FBIOP | Sell (S) | −12,000 | -$42.6K | EDGAR |
| 2017-12-14 | FBIOP | Mixed | +105,407 | -$159.7K | EDGAR |
| 2016-09-19 | FBIO | Sell (S) | −48,912 | -$124.6K | EDGAR |
| 2016-09-16 | FBIO | Grant (A) | +150,000 | $0 | EDGAR |
| 2015-09-14 | FBIO | Disp (D) | −54,036 | -$143.5K | EDGAR |
| 2015-09-10 | FBIO | Disp (D) | −25,804 | -$67.0K | EDGAR |
| 2015-09-08 | FBIO | Disp (D) | −2,136 | -$5.6K | EDGAR |
| 2015-09-04 | FBIO | Disp (D) | −43,100 | -$111.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.